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Background: The use of developmental evaluation is increasing as a method for conducting implementation
research. This paper describes the use of developmental evaluation to enhance an ongoing study. The study
develops and implements evidence-based clinical guidelines for deprescribing medications in primary care and
long-term care settings. A unique feature of our approach is our use of a rapid analytical technique.
Methods/Design: The team will carry out two separate analytical processes: first, a rapid analytical process to
provide timely feedback to the guideline development and implementation teams, followed by a meta-evaluation
and second, a comprehensive qualitative analysis of data after the implementation of each guideline and a final
cross-case analysis. Data will be gathered through interviews, through observational techniques leading to the
creation of field notes and narrative reports, and through assembling team documents such as meeting minutes.
Transcripts and documents will be anonymized and organized in NVIVO by case, by sector (primary care or long-term
care), and by implementation site. A narrative case report, directed coding, and open coding steps will be followed.
Clustering and theming will generate a model or action map reflecting the functioning of the participating social
environments.
Discussion: In this study, we will develop three deprescribing guidelines and will implement them in six sites (three
family health teams and three long-term care homes), in a sequential iterative manner encompassing 18 implementation
efforts. The processes of 11 distinct teams within four conceptual categories will be examined: a guideline priority-setting
group, a guideline development methods committee, 3 guideline development teams, and 6 guideline implementation
teams. Our methods will reveal the processes used to develop and implement the guidelines, the role and contribution
of developmental evaluation in strengthening these processes, and the experience of six sites in implementing new
evidence-based clinical guidelines. This research will generate new knowledge about team processes and the uptake
and use of deprescribing guidelines in family health teams and long-term care homes, with a goal of addressing
polypharmacy in Canada. Clinicians and researchers creating clinical guidelines to introduce improvements into daily
practice may benefit from our developmental evaluation approach.
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The use of multiple medications (polypharmacy) by eld-
erly patients is a significant problem in Canada. Fifty-
three percent of seniors in health care institutions and
13 % living in the community surveyed take five or more
medications, and this use increases with age [1]. Health
administrative data shows that 59 % of seniors had
claims for at least five drug classes in 2002, which in-
creased to 66 % by 2012 [2].
Multiple and inappropriate medication use in the elderly
can lead to non-adherence, medication errors, adverse
drug reactions, fall risk, hospitalization, and mortality
[3–11]. Screening tools can identify problematic medica-
tions [12, 13], and published algorithms can help clinicians
to decide if medications should be stopped [14–16]. Small
trials have evaluated the safety of stopping certain medica-
tions; however, no systematically developed guidelines
have been published to help clinicians safely deprescribe
(i.e., stop or decrease doses of medications causing prob-
lems or that are no longer needed).
We brought together four pharmacists, two physicians,
and one social scientist to develop and implement three
deprescribing guidelines in three family health teams
(FHTs) and three long-term care (LTC) homes in Ontario.
Guideline development will use the GRADE (Grading of
Recommendations, Assessment, Development, and Evalu-
ation) framework and AGREE (Appraisal of Guidelines,
Research, and Evaluation) instrument. We are using two
approaches to evaluate the implementation and uptake of
these guidelines. First, we are using developmental evalu-
ation (DE) to facilitate learning and improvement within
our guideline development and implementation teams.
Second, we are treating our development and implementa-
tion of three guidelines in six healthcare sites (representing
18 separate implementation efforts) as a natural laboratory
for studying local strategies for implementing guidelines.
This paper explains our rationale for designing a project
to create clinical guidelines, our use of DE to strengthen
our process, and our use of a qualitative, multiple case
study design to generate new knowledge about guideline
implementation processes.
The affordances and constraints of clinical
guidelines
Clinical guidelines are both a popular and problematic
way to introduce new approaches into frontline health
care sites, though it is unclear how many physicians are
actually using them [17–21]. Bell and colleagues (2013)
estimate that there are “… at least 2400 guidelines in the
Agency for Healthcare Research and Quality’s National
Guideline Clearinghouse; more than 6400 guidelines in
the database of the Guidelines International Network;
and more than 2700 in the Canadian Medical Associa-
tion’s CPG database” [17].Several studies have explored barriers to guideline im-
plementation. Cabana and colleagues [22] reviewed 76
studies and identified 293 barriers to physician use of
guidelines, including unawareness of the guideline, un-
familiarity and disagreement with the recommendations,
and low self-efficacy to implement recommendations. A
Netherlands’ meta-review indicated that multi-faceted
guideline implementation strategies are the most effect-
ive [23]. However, we are not yet able to predict which
dissemination and implementation approaches are ef-
fective in different circumstances [24, 25].
Many studies have focused on specific instances of
guideline implementation. These studies have identified
hospital policies and management systems, leadership ap-
proaches, economic arrangements, time constraints, health
care provider motivations, and patient motivations as bar-
riers to guideline adoption [26–28]. Difficulties can also
arise when opinions differ about the relative importance of
using scientific evidence and clinical experience [29].
We have much to learn about guideline implementation
[30, 31]. Some suggest that new approaches to knowledge
translation might emphasize interaction processes rather
than knowledge products such as clinical guidelines [32].
Gabbay and le May argue that clinicians rarely use guide-
lines and instead rely on collective knowledge sources that
are embedded in the activities and artifacts of a practice
[33, 34]. They use the term “mindlines” to refer to this
fluid knowledge source, which is influenced by scientific
findings, clinical judgment, organizational constraints, and
ongoing interactions with peers. Lomas writes: “The ap-
proach to knowledge management in health services has
generally been to try and deliver better-researched facts to
clinicians and to try and help them to make good use of
such facts. But this strategy assumes a rational and indi-
vidualistic approach to knowledge acquisition that flies in
the face of all the evidence about what some have called
‘the social life’ of knowledge—the intricate, convoluted
and confusing pathways by which people in an
organization negotiate, adapt and transform new know-
ledge that is often far from factual” [33].
Despite questions about the usefulness of guidelines,
we opted to develop and implement three deprescribing
guidelines in light of our clinical experiences and the
paucity of literature in how to safely decrease or discon-
tinue medications. Our project also attempts to pinpoint
factors that influence attitudes and behaviors in complex
social environments where guideline development and
implementation occurs.
Using developmental evaluation to address
challenges related to innovations, programs, and
interventions in complex environments
We use DE to identify effective and ineffective aspects of
the guideline development and implementation processes
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practice-site teams for their consideration. DE, with its
complexity perspective, recognizes the importance of
adapting programs to the circumstances of complex social
environments [35–37]. When an intervention takes place
under complex conditions, numerous factors interact with
and influence each other, making it impossible to predict
what will happen as the intervention moves forward. Pat-
ton suggests that such evaluations call for a focus on an
interconnected web of relationships and influences [37].
A DE evaluator gathers data about the factors affecting a
program’s functioning within a complex environment and
helps innovators adapt to new circumstances [37, 38].
DE is useful when adapting a program to emerging con-
ditions, modifying approaches for use in new contexts, de-
veloping scalable innovations, and generating feedback
about an innovation as it moves forward [37, 39]. These
uses are analogous to our development and testing of
deprescribing guidelines.
Although a new method [37, 40], DE is being used by
many health care researchers and evaluators. DE has
been used to reveal program impacts [35], to facilitate
social innovation through public health interventions
[41], to reveal team dynamics that promote program
development [42], to facilitate discussion of the impact
of research [43], and to facilitate change through team
dialog [44].
Issues and challenges typical of DE
Three challenges have been identified by research teams
using DE [41]. First, DE evaluators are interested in gen-
erating actionable knowledge to help their own team as
opposed to generating knowledge applicable to other
cases. Second, a DE evaluator is both a program team
member and an evaluator of the team’s work, thus creat-
ing a significant cognitive burden. Third, the short time-
frames needed for gathering and presenting DE data may
differ from the longer timeframes needed for a thorough
analysis of research data, thus delaying DE feedback
sessions or rushing research analysis.
Our approach mitigates these risks in several ways.
First, we will use separate analytical processes to meet
our DE objectives and our research objectives. Our DE
analysis is based on the qualitative technique of analyt-
ical memoing (described later in the paper) and will
move forward in brief, rapid phases, while the full quali-
tative analysis is carried out in three increments after
creation and implementation of each guideline.
We address the problem of the dual role by rotating
the membership on our DE team, so several investiga-
tors and staff will have the experience of participating on
guideline development teams and on the DE team. One
principal investigator (the first author of this paper) will
act as the DE team’s overall lead and will train new teammembers. All who participate in the DE work will create
“bias statements” that identify potential conflicts that
could arise; these are revisited and discussed at specific
points during the project.
To strengthen our DE approach, we will conduct a
meta-evaluation at three points during the project [45].
This involves considering our DE processes in terms of
The Program Evaluation Standards [46]. This will require
the DE team to reflect on and discuss issues concerning
potential conflicts of interest, the adequacy of information
sources, the appropriateness of data collection and analyt-
ical procedures, the extent of the evidence to support
evaluation conclusions, and the impartiality of the feed-
back process.
A design encompassing the goals of DE and
translational research
We created eight research questions to contribute to an
understanding of guideline development and implementa-
tion. These questions explore the use of consensus ap-
proaches to identify guideline topics and the impact of
guidelines on clinician self-efficacy [see Additional File 1].
This paper describes our use of DE with the guideline
development and implementation experiences of the six
participating sites. The following research questions are
relevant:
 What development and implementation processes
can be used to create and introduce deprescribing
guidelines into primary care and LTC contexts that
positively influence the adoption and use of the
practices described in the guideline?
 What are the barriers and facilitators to the use of
deprescribing guidelines in primary care and LTC
care contexts?
 What is the uptake and effect of deprescribing
guidelines by health care professionals in primary
care and LTC contexts?
To investigate these questions, we will develop and
implement three deprescribing guidelines to assist pre-
scribers in tapering and stopping medications that may
no longer be needed or that can cause adverse effects in
the elderly. The guidelines will be developed and imple-
mented in a sequential, iterative manner. We begin by
developing the first guideline and implementing it in
three LTC facilities and three FHTs in Ontario. After
this, we develop and implement the second and then the
third guidelines.
As this work unfolds, we will gather data about our
own processes to inform an ongoing DE process of
learning and improvement to enhance the capacity of
participating teams. We will also use the data to gener-
ate new knowledge about team processes and
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mentation of clinical guidelines. The latter, which we
refer to as our translational research subproject, relies
on the same data as the DE process but uses more com-
prehensive analytical procedures.
This project is a multiple case study [47–49]. Each case
involves the development of a deprescribing guideline and
its implementation into six frontline sites. Each of the
three guidelines will be a case. We chose qualitative
methods as we intend to study in detail the processes
for developing and implementing guidelines [50] as
they occur in their natural settings [51]. Our purpose is
to explore the phenomena and to generate a detailed
description of these processes [52].
Our case reports will include separate sections that de-
scribe each site’s implementation experience, findings
from each of the two sectors (FHTs and LTC) considered
separately, and a comparison of the findings. The strength
of our approach lies in its ability to capture aggregate data
to inform the experience of the FHTs and LTC homes as a
whole, while also allowing us to provide information at
the individual practice level.
Incorporating developmental evaluation into the
design
We devised a DE learning framework based on the idea
that human actions are informed by intentions, and that
human intentionality consists of beliefs (values, aspira-
tions, assumptions) and knowledge (understanding of
facts, usually based on evidence provided through experi-
ence) [37, 53]. Our DE process will reveal team member
beliefs and knowledge, along with actions taken and re-
sults produced. These data will be fed into a deliberativeAction
Beliefs Knowledge
Over time, the developmental evaluation p
results in action being based less on belie
time
Fig. 1 Evaluation learning framework for creating and implementing depreprocess to allow team members to learn from their ac-
tions. This learning framework is illustrated in Fig. 1.
When the project begins, team members will have be-
liefs about how to implement the guidelines in the sites.
As we work together, we will gather, analyze, and discuss
data about our own development and implementation
processes, which will allow us to identify and implement
improvements.
Data collection approach
We created a single data collection approach to meet the
needs of the DE evaluation and translational research
subproject and separate analytical approaches for the
DE evaluation and translational research (see Fig. 2).
The rest of this paper describes our research setting,
data gathering approach, and analytical methods.
Research setting
Figure 3 depicts the research setting.
Our research setting includes 11 groups organized into
four conceptual categories:
 A single group that participated in a priority-setting
meeting as part of a process to select guideline topics
 A single group known as the guideline development
methods committee (GDMC)
 Three guideline development teams (GDTs), each
responsible for developing one guideline
 Six site implementation teams, three each from
FHTs and LTC homes
The priority-setting meeting is part of a Delphi consen-
sus process to identify medication classes for the threeAction
Beliefs Knowledge
rocess will promote learning that 
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Fig. 2 Shared data gathering and separate analytical methods
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tured process for communicating and making decisions,
which brings together a panel of experts who participate
in several rounds of survey questionnaires. To design this
process, team members came together for a priority-setting
meeting to discuss interests and objectives, potential Delphi
participants, and the survey design [54].
The GDMC consists of members of the investigator
team with experience and/or interest in guideline develop-
ment. This team determines and oversees the methods
used by the three GDTs.
The research setting includes three GDTs established at
different points during the project. Their role is to develop
one evidence-based clinical guideline each. This work in-
volves following the processes and standards determined
by the GDMC, establishing roles and responsibilities, car-
rying out systematic reviews, reviewing the evidence,
reaching agreement on guideline recommendations, creat-
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Fig. 3 The research settingthe results of the team’s work, presenting the guideline to
the six implementation sites, and preparing articles for
publication.
The research setting also includes the six sites that will
implement the guidelines in their practices and provide
us with data about their experiences. These Ontario
FHTs and LTC homes were selected from interprofes-
sional practices located in the Ottawa region that in-
clude a pharmacist.
Data gathering methods
The project has four phases. Phases 1–3 focus on gather-
ing and analyzing data related to each of the guidelines,
while phase 4 involves a cross-case analysis.
Guarding against confirmation bias
To guard against confirmation bias, team members who
produce field notes will create a comprehensive record of
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agenda topics. Observers look for, and record, behaviors
focused on the task at hand and the effectiveness of the
team [55, 56]. Observers separate what they observe
(behaviors and utterances) from interpretations. The
field note template (see Additional file 2) encourages
this distinction [50, 57, 58].
At least two team members will observe meetings and
create field notes. Because researchers involved in data
gathering have varied backgrounds (e.g., occupational
therapy, psychology, pharmacy, medicine, social science),
they will be subject to different occupational biases. We
will use audio recordings to verify field note content.
Those who participate in gathering and analyzing data
will create “bias statements” which summarize beliefs
about deprescribing and guidelines. Team members with
strong opinions about polypharmacy, the usefulness of
evidence-based guidelines, or the most effective ways of
implementing guidelines will identify and record those
opinions in their bias statements. They will periodically
review and reflect individually and collectively on how
their views may influence how they collect, analyze, and
interpret data.
Phase 1 data collection
An overview of our data collection approaches for the
various phases is presented in Additional file 3.
Data will be collected through observations resulting in
field notes, as well as through narrative reports, inter-
views, and a review of relevant documents (such as meet-
ing minutes). The activities that make up phase 1 are
slightly different from those of subsequent phases, because
phase 1 includes the consensus process to identify the
topics of the three guidelines. For phase 1, we will gather
data about the consensus process and about the develop-
ment and implementation of the first guideline.
One investigator (JC) has primary responsibility for
the data gathering and analysis methods used for the
translational research and DE process. A method docu-
ment will be created by this investigator and used to
train those who participate in data gathering and ana-
lysis activities. This document explains when and how
data is gathered and includes templates for field notes
and interviews. Additional file 2 contains the field notes
and one interview template, as examples.
During phase 1, a Delphi consensus process will be used
to identify the topics for the three deprescribing guidelines
[54]. The consensus process includes a priority-setting
meeting to discuss design issues. Two team members will
observe the meeting to produce field notes. Attendees will
also produce brief narrative reports that document their
meeting experience. These data will help us to consider
how the consensus approach influences subsequent pro-
ject activities.We will seek to understand the functioning and influence
of the GDMC by conducting semi-structured interviews
with three committee members (a concluding interview
with the same team members will be conducted in phase
3). All interviews conducted during the project will be digit-
ally recorded, and a transcript will be created. We will also
collect documents produced or used by this committee.
We will gather data about the first GDT by observing
meetings and conducting interviews. Two observers will
attend two meetings of the team and will produce field
notes. We will conduct two semi-structured interviews
of two team members (the team leader and coordinator),
one at the beginning and one toward the end of the
team’s process. We will also interview the two GDT
members who carry out the systematic reviews that
compile the evidence on which the guideline will be
based. Finally, we will collect and review documents pro-
duced or used by the GDT.
Phase 1 includes capturing data about the processes
used to implement the first guideline into the six sites.
We will observe two implementation meetings at each
site, yielding two field notes from each meeting (24 in
total) and interview two implementation team members
from each site; first, when the site is introduced to the
guideline and the second approximately 3 months later,
yielding 24 interview transcripts from implementation
sites. We will interview 12 prescribers (two at each site)
who used the guideline and will interview patients or
family members from each participating site within
4 months of the intervention. We anticipate conducting
two patient interviews for each site (12 in total). Hence,
during phase 1 we will gather 24 field notes and 48
interview transcripts from the implementation sites.
Our dataset for phase 1 will thus include a minimum
of 30 field notes and 57 interview transcripts.
Phase 2 and phase 3 data collection
Data collection during phases 2 and 3 will be identical
to phase 1, with these exceptions:
 The consensus process will be complete and thus no
additional data will be gathered from that process
 In phase 2, we may collect relevant documents from
the GDMC, and we will gather no interview data
from the committee
 In phase 3, we may continue to collect relevant
documents from the GDMC, and we will conduct
semi-structured interviews with three committee
members
Our dataset (aside from documents) for phase 2 will
thus include a minimum of 28 field notes and 54 inter-
view transcripts, and our dataset for phase 3 will include
28 field notes and 57 interview transcripts.
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gathering approach in the three phases.
Analytical methods
We will use two analytical processes. The first will be a
rapid process that allows the DE team to feedback data
to the guideline development and implementation teams.
This DE analysis includes a meta-evaluation that con-
siders how the DE process could be improved. The sec-
ond analytical process is a comprehensive investigation
of patterns that characterize the participating teams over
the course of the study. We will use NVIVO to organize
data by case, by sector (FHT and LTC), and by partici-
pating site. We describe these two processes below.
Rapid DE analytical process
The rapid DE analytical process ensures that lessons
learned are available to the project teams in time for
them to have an impact on team performance. Findings
from the first guideline iteration will inform the second
iteration, and findings from the second iteration will in-
form the third.
A team of DE analysts will review segments of the data
to provide feedback to the guideline development and im-
plementation teams. A minimum of three analysts will
participate in each review. Each segment of data will focus
on work that was conducted to develop or implement one
of the guidelines. One segment will focus on the data gath-
ered from the priority-setting meeting, a second segment
will focus on the early work of the first guideline develop-
ment team, a third will focus on the hand-over of the first
guideline to the implementation sites, and so on.
The DE analysis team will produce two deliverables.
The first will be analytical memos, produced by each
member as they review the data. Memos will identify
patterns evident in the data and insights that occur for
the analyst as s/he reviews the data. Analytical memoing
is a standard qualitative analysis technique for recording
insights and interpretations as analytical procedures are
implemented [50, 59]. Our team will use this technique
to identify potential improvements in team functioning.
Completed memos will be distributed to members of
the DE analysis team, who will read them, noting pat-
terns and implications. The team then meets to create
their second deliverable: a set of lessons learned to
present to the guideline development and implementa-
tion teams. After the meeting, one analyst prepares a
summary of the lessons. The feedback presentation will
consist of lessons learned and a discussion of potential
changes to team structures or processes.
Meta-evaluation of the DE process
At the end of each guideline development and implemen-
tation cycle, three analysts will conduct a meta-evaluationof the work that has been done for that guideline. The
meta-evaluation will be based on standards from The
Program Evaluation Standards [49, 50] covering issues
of utility, feasibility, ethics, and accuracy. Team members
will individually read through a summary of the standards
and make notes about how the standard applies to the
work carried out in this iteration. The meta-evaluation
team will then meet to share reflections and to discuss
changes to the DE process. This meeting will yield a report
that presents findings and proposed changes.
Comprehensive qualitative analysis for the translational
research subproject
The comprehensive analytical procedure includes a data
review that produces a narrative case report, a directed
coding step, and an open coding step. These procedures
will be conducted by three team members and will gen-
erate three case study reports, one for the development
and implementation of each guideline. The reports
will provide a narrative account of the case, answers
to the research questions, and an open-ended explor-
ation of the data that might yield unanticipated dis-
coveries [49, 60, 61]. They will also form the basis for
the phase 4 cross-case analysis [48].
Data review and narrative case report writing
To conduct the data review, one analyst reads through
all of the data. Because the case studies concern events
that unfolded through time and in specific groups and
locations, one analyst will review the data sequentially
and in terms of the teams and sites from which the data
was gathered. When reviewing the data from the imple-
mentation teams, the analyst will first look at the FHTs
(starting with the first guideline) and then at the LTC
sites (again starting with the first guideline). The analyst
then writes a description of what happened during the
development and implementation of the guideline. This
descriptive story forms the first part of the case report.
Two other analysts review the draft, after which a final
draft is produced.
Directed coding
We will use a directed coding approach to generate an-
swers to the research questions. The analyst will use a
predetermined coding list developed from our research
questions and DE framework to code portions of data
[62, 63]. Additional file 4 presents our directed codes.
Directed coding will be carried out on the full qualita-
tive data set, with the data grouped and coded in terms
of the four categories that make up the research setting.
Data from the guideline development teams will be
coded as a self-contained segment, and data from each
implementation site will be coded separately. This allows
us to draw conclusions about each team, about the FHT
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experience.
This analysis is carried out by three team members.
Two analysts will code approximately five identical pages
of data. The full coding team then reviews the coded
data, discussing and resolving discrepancies. One analyst
then codes the rest of the data. When coding is
complete, the coding team reviews and resolves issues
and concerns. One analyst then reads through the coded
data and creates a nuanced and complete statement in
relation to that directed code (this could be an answer
to one of the research questions or a statement concern-
ing an aspect of the evaluation framework). Statements
are reviewed and finalized before being added to the ap-
propriate section of the case report.
Open coding
Open coding allows us to discover meaning in the data
beyond that related to the research questions or evalu-
ation framework. It allows the analyst to invent a classi-
fication scheme that emerges from the data [50, 62, 64].
Open coding will be performed on field notes, narra-
tive reports, interview data, and documents. Analysts
performing the open coding will distinguish between
codes that apply to guideline development teams and to
each FHT and LTC implementation teams. Codes will be
defined to clearly indicate which context or group it re-
lates to. If the meaning associated with one code also ap-
pears in other contexts or groups, additional codes can
be created to capture these meanings. The open coding
process will thus identify patterns that apply to a single
implementation site or to multiple sites.
Open coding is conducted by three analysts. To begin,
two analysts individually carry out open coding on five
identical pages of data. The third analyst then joins them
to review the coded data and pinpoint similarities and
differences in codes that have been generated. At the
end of this session, the participants agree on which
codes to retain and which (if any) to discard. They also
finalize the names and definitions of the codes.
One analyst then codes the rest of the data, noting is-
sues or concerns that arise. As the coding proceeds, a
second analyst will rejoin the effort on three occasions
for one hour. During this time, the two analysts discuss
and agree on codes for the section of data that is dealt
with during the time frame, and they discuss issues that
have arisen during the coding process.
The analyst who carried out the open coding then
considers the strength of the codes by identifying how
many times each code appears in the dataset and the
number of data sources each code derives from. The
analyst examines codes that appear infrequently, and in
few data sources, and considers if any of these weak
codes should be discarded. At this point, the threeanalysts review, discuss and resolve issues and concerns,
and finalize the open codes.
Clustering and theming the open codes
Our clustering and theming procedure will reveal pat-
terns that are evident in what participants say and do
over the course of each iteration [52, 58, 60, 65–67]. It
reveals patterns evident in their thinking (their inten-
tions, beliefs, interpretations, and conclusions) and in
the actions undertaken and results produced.
The clustering and theming process begins when open
coding is complete and is consistent with procedures
recommended by Braun and Clarke (2006) [67] and with
the facilitation technique developed by the Institute for
Cultural Affairs [65, 66]. Clustering will be done collab-
oratively by three analysts and includes a step to agree
on a name, summary description, and detailed narrative
description for each theme. Once themes have been
agreed upon, the analysts consider how the patterns of
thought and action revealed in the themes interact with
each other to produce complex social environments that
display an impulse toward improvement and change and
a countering impulse toward stability and resistance.
The final step will be to create a model to depict the
functioning of these social environments [53, 68–70].
Cross-case analysis
The comprehensive qualitative analysis will be carried out
once for each iteration of guideline development and im-
plementation. The output from each round of analysis will
be a case study report. Following this, we will conduct a
cross-case analysis of the three case studies.
To do this, one analyst reviews the three case reports
and writes summary descriptions of what the cases re-
veal about the functioning of guideline development and
implementation teams; what changes and improvements
are evident in the second and third guideline develop-
ment and implementation processes; how patterns of
thought, action, and structuring changed over the course
of the three iterations; what results were achieved by the
teams; what accounts for differences between the teams;
what roles are evident among members of the participat-
ing teams; and what barriers and facilitators of develop-
ment and implementation are evident in the three cases.
The analyst then compares the themes and models
generated in the three cases and considers if some
themes are evident across cases and whether changes in
the thematic content of the cases suggest a process of
improvement across iterations. The analyst also com-
pares the models from the three cases.
The analyst concludes the cross-case analysis by com-
paring the answers to the research questions that were
generated in the three cases. The analyst then creates a
final answer for each research question based on an
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similarities and differences across the cases and offering
explanations of differences. The analyst prepares a cross-
case report to be distributed to the investigator team,
which is finalized following agreed-upon revisions.Ethics approval
This protocol received ethics approval from the Bruyère
Research Ethics Board (REB) (#M16-13-029); the Univer-
sity Human Research Ethics Committee (REC) at Concor-
dia University (#30001626); the Ottawa Health Science
Network REB (#20130589-10H); the Health Sciences REB
at the University of Toronto (#29174); and the University
of Waterloo REC (#19086).Discussion
Our research project seeks to strengthen the develop-
ment and implementation of guidelines produced by our
project teams while simultaneously studying the imple-
mentation processes used in six participating sites. We
hope to offer recommendations to strengthen the rele-
vance and uptake of research findings by incorporating re-
flective processes such as DE, action learning [71, 72], the
plan-do-study-act cycle [73], or appreciative inquiry [74].
We also hope to build on the work of Anderson and col-
leagues [75] to further the understanding of barriers to
and facilitators of developing and implementing depre-
scribing guidelines in primary care and LTC settings.
This research will contribute to our understanding of the
ways in which DE might be incorporated into an imple-
mentation science research project and of the contribution
that DE can make to a project’s knowledge translation
goals. We will explore whether a rapid analytical procedure
using analytical memos might overcome some challenges
encountered by other researchers [41]. We will also dis-
cover whether guideline development teams and site
implementation teams experience DE as having a posi-
tive (or negative) impact on their efforts to develop and
implement deprescribing guidelines.
This research will generate new knowledge concerning
the uptake and use of evidence-based deprescribing
guidelines in frontline FHT and LTC sites. Recent re-
search indicates that recommendations presented in
evidence-based clinical guidelines are not integrated into
practice through a simple, linear process but rather must
penetrate complex ways of knowing and acting [33, 34].
Our research will follow the work of six implementation
teams as they introduce deprescribing guidelines to cli-
nicians and patients in their practice and will document
the barriers and facilitators that they encounter. Our
methods will allow us to identify experiences that are
unique to a single site and those that are relevant for
several sites.Finally, the implementation science component of our
project is nested within a broader project whose purpose
is to ameliorate the serious problem of polypharmacy
among Canada’s elderly. The rapid cycles of feedback en-
abled by DE allow for improvement of the processes
through each iteration of guideline development and im-
plementation. Ultimately, our project will produce guide-
line development and implementation methods that can
be used for other medication classes, thus facilitating
reach and impact of deprescribing guideline interventions
with the aim of improving health in older persons.
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